Kynteles (vedolizumab) for injection is used for the treatment of ulcerative colitis, Crohn’s Disease..

Takeda launches IBD medication Kynteles in India. Used to treat Ulcerative Colitis and Crohn’s Disease as well, the drug expands the company’s GI portfolio in the country. Kynteles is used for the treatment of adult patients with moderate to severely active ulcerative colitis (UC) and Crohn’s Disease (CD). Kynteles, more widely known as Entvyio, has shown favourable safety and efficacy results in treating patients suffering from moderate to severe IBD.

Kynteles (vedolizumab) for injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Kynteles (vedolizumab) for injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Kynteles (vedolizumab) for injection medicine cost price in India.

The order for Kynteles (vedolizumab) for injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Vedolizumab (trade name Entyvio) is a monoclonal antibody developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name Entyvio.

Kynteles (vedolizumab) for injection, for intravenous use Initial U.S. Approval: 2014

Generic Name: vedolizumab

For injection: 300 mg of lyophilized vedolizumab in a single-use 20 mL vial

Kynteles (vedolizumab) for injection

Kynteles (vedolizumab) injection is available.

Get In Touch

Kynteles (vedolizumab) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Kynteles (vedolizumab) on prescription and Import License in Patient's Name only.

For overseas patients, Kynteles (vedolizumab) can be made available in Send your enquiry to find Kynteles (vedolizumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Kynteles (vedolizumab).

Dosage Forms and Strengths: For injection 300 mg of lyophilized vedolizumab in a single-use 20 mL vial. ReadMore

Takeda India launches Kynteles medicine for IBD patients ReadMore

Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease ReadMore

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur